Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Novel Warfarin Composite Measure May Aid Comparison of Anticoagulation Performance

By Will Boggs, MD, Reuters Health | on November 5, 2015 | 0 Comment
Uncategorized
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

NEW YORK—A novel warfarin composite measure (WCM) that combines percent time in therapeutic range (TTR) and international normalized ratio (INR) variability might be useful in comparing anticoagulation clinic performance rankings, researchers report.

You Might Also Like
  • Similar Outcomes of Cervical-Artery Dissection With Antiplatelet, Anticoagulation Therapy
  • NOAC Bleeding No More Dangerous than Warfarin Bleeding
  • Reversal of Anticoagulation

TTR reflects the intensity of anticoagulation, whereas INR variability reflects its stability. Both are important measures of anticoagulation quality, and previous studies have suggested their combination provides added value.

Dr. Zayd Razouki from the Durham VA Medical Center in North Carolina and colleagues developed the WCM, which combines standardized TTR and standardized log INR variability, and examined its feasibility for profiling anticoagulation clinics in the Veterans Health Administration.

WCM’s hazard ratios for fatal bleeding and ischemic stroke were greater with very poor control or poor control, compared with those with TTR or INR variability, the researchers report in Circulation Cardiovascular Quality and Outcomes, online September 29.
In contrast, WCM’s hazard ratios for major bleeding were larger than those with INR variability but not significantly different from those with TTR.

As for patient level outcomes, WCM was no better than TTR or INR variability.
At the anticoagulation clinic level, WCM reconciled moderately well the discordance in rankings that occurred when using TTR or INR variability separately.

“We would recommend the use of WCM as a performance measure for clinic profiling, as it seems to identify different clinics as outliers,” the researchers conclude. “Both on an empirical and a theoretical basis, WCM captures more completely relevant dimensions of anticoagulation control than its component measures.”

Dr. Gabriel Vanerio from CASMU Arrhythmia Service in Montevideo, Uruguay, recently demonstrated the usefulness of INR variability for assessing anticoagulation quality. While admitting that the WCM is “very well constructed,” he told Reuters Health by email, “I do not believe that this new measurement will be clinically useful.”

Instead, Dr. Vanerio suggested that physicians should take home “the importance of anticoagulation quality control” as the main message of this report. Dr. Razouki did not respond to a request for comments.

Topics: anticoagulationclinicmeasurePerformanceQualitywarfarin

Related

  • July 2024 News from the College

    July 6, 2024 - 0 Comment
  • June 2024 News from the College

    June 11, 2024 - 0 Comment
  • Tips for Managing Acute Agitation in the Elderly

    June 13, 2022 - 0 Comment

Current Issue

ACEP Now May 03

Download PDF

Read More

No Responses to “Novel Warfarin Composite Measure May Aid Comparison of Anticoagulation Performance”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Current Issue

ACEP Now May 03

Download PDF

Read More

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603